Retrieve available abstracts of 27 articles: HTML format
Single Articles
June 2025
WANG W, Yang H, Passang T, Li Y, et al Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver
Metastasis.
Cancer Lett. 2025 Jun 5:217855. doi: 10.1016/j.canlet.2025.217855. PubMedAbstract available
April 2025
TANG R, Xu X, Yang W, Yu W, et al Corrigendum to "MED27 promotes melanoma growth by targeting AKT/MAPK and
NF/kappaB/iNOS signaling pathway" [Cancer Lett. 373(1) (2016) 77-87 PMID 26797421].
Cancer Lett. 2025;623:217717. PubMed
TIAN H, Chen Y, Dong X, Fan X, et al The m(6)A hypermethylation-induced PIR overexpression regulates H3K4me3 and
promotes Tumorigenesis of Uveal Melanoma.
Cancer Lett. 2025 Apr 17:217729. doi: 10.1016/j.canlet.2025.217729. PubMedAbstract available
March 2025
HOSSAIN SM, Gimenez G, Stockwell P, Weeks R, et al Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma
response to anti-PD1 immunotherapy.
Cancer Lett. 2025 Mar 13:217638. doi: 10.1016/j.canlet.2025.217638. PubMedAbstract available
UHER O, Hadrava Vanova K, Labitt R, Petrlakova K, et al Neoadjuvant intratumoral MBT(A) immunotherapy prevents distant metastases and
recurrence in murine models.
Cancer Lett. 2025;612:217464. PubMedAbstract available
February 2025
MARRANCI A, Maresca L, Lodovichi S, Luserna di Rora AG, et al PARP1 in Melanoma: Mechanistic Insights and Implications for Basic and Clinical
Research.
Cancer Lett. 2025 Feb 28:217599. doi: 10.1016/j.canlet.2025.217599. PubMedAbstract available
URZI O, Olofsson Bagge R, Crescitelli R Extracellular vesicles in uveal melanoma - biological roles and diagnostic value.
Cancer Lett. 2025 Feb 4:217531. doi: 10.1016/j.canlet.2025.217531. PubMedAbstract available
November 2024
TRAPPETTI V, Fernandez-Palomo C, Arora P, Potez M, et al "Towards melanoma in situ vaccination with multiple ultra-narrow X-ray beams".
Cancer Lett. 2024 Nov 13:217326. doi: 10.1016/j.canlet.2024.217326. PubMedAbstract available
August 2024
GAO Q, Li N, Pan Y, Chu P, et al Hepatocyte growth factor promotes melanoma metastasis through ubiquitin-specific
peptidase 22-mediated integrins upregulation.
Cancer Lett. 2024 Aug 31:217196. doi: 10.1016/j.canlet.2024.217196. PubMedAbstract available
FLETCHER K, Cortellini A, Ganta T, Kankaria R, et al Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients
80 years or older: A retrospective cohort study.
Cancer Lett. 2024;596:217001. PubMedAbstract available
KIM YJ, Lee M, Kim EH, Lee S, et al Real-world incidences and risk factors of immune-related adverse events in
patients treated with immune checkpoint inhibitors: A nationwide retrospective
cohort study.
Cancer Lett. 2024;596:216998. PubMedAbstract available
July 2024
LIU M, Zhao Z, Wang C, Sang S, et al Harnessing genetic interactions for prediction of immune checkpoint inhibitors
response signature in cancer cells.
Cancer Lett. 2024;594:216991. PubMedAbstract available
FU Z, Zhang L, Chen R, Zhan J, et al Biphasic co-detection of melanoma aneuploid tumor cells and tumor endothelial
cells in guidance of specifying the field cancerized surgical excision margin and
administering immunotherapy.
Cancer Lett. 2024;598:217099. PubMedAbstract available
June 2024
ZHANG X, Cui X, Li P, Zhao Y, et al EGC enhances tumor antigen presentation and CD8(+) T cell-mediated antitumor
immunity via targeting oncoprotein SND1.
Cancer Lett. 2024;592:216934. PubMedAbstract available
LIAO Q, Shi H, Yang J, Ge S, et al FTO elicits tumor neovascularization in cancer-associated fibroblasts through
eliminating m(6)A modifications of multiple pro-angiogenic factors.
Cancer Lett. 2024;592:216911. PubMedAbstract available
May 2024
WANG J, Hirose H, Du G, Chong K, et al Corrigendum to "P-REX1 amplification promotes progression of cutaneous
melanomavia the PAK1/P38/MMP-2 pathway" [Cancer Lett. 407 (2017) 66-75].
Cancer Lett. 2024 May 23:216966. doi: 10.1016/j.canlet.2024.216966. PubMed
April 2024
JIA Y, Zhang F, Meng X, Andreev D, et al Osteocytes support bone metastasis of melanoma cells by CXCL5.
Cancer Lett. 2024 Apr 6:216866. doi: 10.1016/j.canlet.2024.216866. PubMedAbstract available
WANG L, Liu X, Han Y, Tsai HI, et al TRAF6 enhances PD-L1 expression through YAP1-TFCP2 signaling in melanoma.
Cancer Lett. 2024 Apr 5:216861. doi: 10.1016/j.canlet.2024.216861. PubMedAbstract available
February 2024
MIRZAEI H, Salehi H, Oskuee RK, Mohammadpour A, et al Retraction notice to "The therapeutic potential of human adipose-derived
mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis
model" [Cancer Lett. 419 (2018) 30-39].
Cancer Lett. 2024 Feb 2:216670. doi: 10.1016/j.canlet.2024.216670. PubMedAbstract available
January 2024
ZHANG J, Joshua AM, Yue L, O'Meara CH, et al Targeted therapy, immunotherapy, and small molecules and peptidomimetics as
emerging immunoregulatory agents for melanoma.
Cancer Lett. 2024 Jan 26:216633. doi: 10.1016/j.canlet.2024.216633. PubMedAbstract available
LIU C, Cheng X, Han K, Hong L, et al A novel molecular subtyping based on multi-omics analysis for prognosis
predicting in colorectal melanoma: A 16-year prospective multicentric study.
Cancer Lett. 2024 Jan 19:216663. doi: 10.1016/j.canlet.2024.216663. PubMedAbstract available
November 2023
CERDIDO S, Abrisqueta M, Sanchez-Beltran J, Lambertos A, et al MGRN1 depletion promotes intercellular adhesion in melanoma by upregulation of
E-cadherin and inhibition of CDC42.
Cancer Lett. 2023;581:216484. PubMedAbstract available
HU X, Hu Z, Zhang H, Zhang N, et al Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics
and single-cell transcriptome analyses.
Cancer Lett. 2023 Nov 7:216466. doi: 10.1016/j.canlet.2023.216466. PubMedAbstract available
September 2023
XU M, Li S Nano-drug delivery system targeting tumor microenvironment: A prospective
strategy for melanoma treatment.
Cancer Lett. 2023 Sep 18:216397. doi: 10.1016/j.canlet.2023.216397. PubMedAbstract available
July 2023
ZHANG X, Hu Z, Wang X, Li L, et al Corrigendum to "ANXA10 promotes melanoma metastasis by suppressing E3 ligase
TRIM41-directed PKD1 degradation" [Cancer Lett. 519 (2021) 237-249].
Cancer Lett. 2023 Jul 18:216310. doi: 10.1016/j.canlet.2023.216310. PubMed
April 2023
ZHAN D, Zheng N, Zhao B, Cheng F, et al Expanding individualized therapeutic options via genoproteomics.
Cancer Lett. 2023;560:216123. PubMedAbstract available
March 2023
ZHAO J, Gao N, Xu J, Zhu X, et al Novel strategies in melanoma treatment using silver nanoparticles.
Cancer Lett. 2023 Mar 27:216148. doi: 10.1016/j.canlet.2023.216148. PubMedAbstract available